Cytogenetic and Molecular Genetic Aspects of Chronic Myeloid Leukaemia

By  

Acta Haematologica, Vol. 108, Iss. 4, 2002-11 ,pp. : 180-202

Karger

Access to resources Recommend Favorite

Evaluation of Long-Term Outcomes, Cytogenetic and Molecular Responses with Imatinib Mesylate in Early and Late Chronic-Phase Chronic Myeloid Leukemia: A Report from a Single Institute

By  

Acta Haematologica, Vol. 128, Iss. 4, 2012-08 ,pp. : 223-232

Karger

Access to resources Recommend Favorite

Cytogenetic and Molecular Monitoring of Residual Disease in Chronic Myeloid Leukaemia

By  

Acta Haematologica, Vol. 107, Iss. 2, 2002-03 ,pp. : 64-75

Karger

Access to resources Recommend Favorite

Continuous Complete Hematological and Cytogenetic Remission with Molecular Minimal Residual Disease 9 Years after Discontinuation of Interferon-α in a Patient with Philadelphia Chromosome-Positive Chronic Myeloid Leukemia

By  

Acta Haematologica, Vol. 115, Iss. 1-2, 2006-01 ,pp. : 109-112

Karger

Access to resources Recommend Favorite

Molecular monitoring of chronic myeloid leukemia: a personalized approach to optimizing treatment response

By Nichols Linda   Pippins Julie   Castle Lon   Cassler Mary   Fuller Courtney  

Personalized Medicine, Vol. 9, Iss. 7, 2012-09 ,pp. : 727-737

Future Medicine

Access to resources Recommend Favorite